Humana
HUM
#766
Rank
C$42.45 B
Marketcap
C$353.02
Share price
-1.52%
Change (1 day)
-12.01%
Change (1 year)

P/E ratio for Humana (HUM)

P/E ratio as of December 2025 (TTM): 23.7

According to Humana's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 23.6688. At the end of 2024 the company had a P/E ratio of 25.2.

P/E ratio history for Humana from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202425.211.81%
202322.60.09%
202222.514.37%
202119.727.13%
202015.5-10.71%
201917.4-21.76%
201822.259.49%
201713.9-69.99%
201646.3138.37%
201519.48.79%
201417.947.17%
201312.148%
20128.21-9.98%
20119.11

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
The Cigna Group
CI
11.8-50.24%๐Ÿ‡บ๐Ÿ‡ธ USA
UnitedHealth
UNH
17.3-27.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Centene
CNC
-3.60-115.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Molina Healthcare
MOH
9.25-60.90%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.